The Biggest Malpractice Risks for Psychiatric Nurse Practitioners (and How to Avoid Claims)
By Jeff Schmidt, CarePro Insurance · Arizona insurance license #9086805 · Updated October 21, 2026
Psychiatric NPs don't face surgical complications, but psych practice has its own claim triggers: a patient's suicide, a controlled-substance prescription that goes wrong, a telehealth visit to a patient in a state where you aren't licensed, or a warning you did or didn't give. After 21 years in healthcare liability insurance, I've learned that most of these cases are won or lost on what's in the chart. This guide covers the biggest risks for PMHNPs and the habits that keep them from turning into claims. If you're shopping for coverage instead, start with our guide to PMHNP malpractice insurance.
This is general risk-management information, not legal or clinical advice. Follow your state's laws, your board's rules, and your organization's policies.
The biggest PMHNP malpractice risks at a glance
Suicide and self-harm: claims turn on whether your risk assessment, safety plan, and follow-up were reasonable and documented.
Controlled-substance prescribing: overdose, dependence, and diversion claims, plus board and DEA scrutiny.
Telehealth across state lines: practicing without a license where the patient is located, and changing federal telemedicine prescribing rules.
Failure to diagnose: missed medical causes, missed bipolar disorder, and missed substance use.
Duty to warn and involuntary holds: state laws differ, and a mistake in either direction can lead to a claim.
Boundary violations: allegations that almost always go to the board.
Ketamine, Spravato, and TMS: strict FDA rules and coverage you need to confirm in writing.
1. Suicide and self-harm
A patient's suicide or serious self-harm is the event psych prescribers worry about most. No one can predict every suicide, and the legal question usually isn't whether the outcome happened. It's whether your assessment and follow-up were reasonable given what you knew.
How to reduce the risk:
Document a suicide risk assessment at intake, at medication changes, and whenever symptoms or circumstances change, including your reasoning, not just a checkbox.
Record the safety plan, who was involved, and how means restriction was discussed.
Match your follow-up interval to the risk you documented, and write down why.
Track no-shows and follow up on them; a missed appointment with a high-risk patient deserves a documented outreach attempt.
Note when you consulted a colleague or supervisor on a difficult case.
2. Controlled-substance prescribing
Stimulants, benzodiazepines, and other scheduled medications bring two kinds of exposure: malpractice claims (overdose, dependence, diversion, dangerous combinations) and regulatory action from your board or the DEA. For many PMHNPs, a prescribing complaint to the board is a more likely event than a lawsuit, which is why license defense coverage matters.
How to reduce the risk:
Check your state's prescription drug monitoring program rules and follow them every time they apply.
Document the diagnosis, the clinical rationale, and the alternatives considered for every controlled prescription.
Use treatment agreements and periodic reassessment for long-term controlled-substance therapy.
Keep your DEA registration current, and confirm it covers each state where you prescribe controlled substances.
Know your state's refill limits. In Arizona, for example, Schedule II prescriptions can't be refilled, Schedule III–IV can be refilled up to five times in six months, and Schedule V up to one year (Arizona Administrative Code R4-19-511).
3. Telehealth prescribing and patients across state lines
Telepsychiatry has made it easy to see patients anywhere, and that's exactly the risk. Two rules matter most:
License where the patient is. You need to be licensed and authorized to practice in the state where your patient is located during the visit. The APRN Compact would create a multistate APRN license, but NCSBN says it won't be implemented until seven states enact it, and four had as of NCSBN's last announcement (NCSBN). Confirm the patient's location at every visit and document it.
Controlled substances by telemedicine. HHS and DEA extended the flexibilities that let DEA-registered practitioners prescribe controlled medications by telemedicine without a prior in-person visit through December 31, 2026, while permanent rules, including a proposed special registration for telemedicine, are finalized (HHS, DEA). Prescriptions still have to be for a legitimate medical purpose and comply with federal and state law. Plan now for possible changes in 2027.
The American Psychiatric Association also advises confirming that your malpractice carrier covers the specific telepsychiatry services you provide (Psychiatry.org). Our PMHNP malpractice insurance guide explains how telehealth coverage works in the program we offer.
4. Failure to diagnose
AANP notes that failure to diagnose and delayed diagnosis are common claims against clinicians (AANP). In psych, that can mean missing a medical cause of psychiatric symptoms, missing bipolar disorder before starting an antidepressant, or missing a substance use disorder.
How to reduce the risk:
Rule out medical causes when the presentation calls for it, and document the workup or referral.
Screen for bipolar disorder and substance use before you start or change medication.
Write down the differential diagnosis you considered, not just the final diagnosis.
Close the loop on labs and referrals you ordered.
5. Duty to warn and duty to protect
Since the California Tarasoff decision in 1976, almost every state has passed a "duty to warn" or "duty to protect" law. Some states make disclosure mandatory and others make it permissive (NCSL). That creates risk in both directions: a warning that wasn't required can lead to a privacy complaint, and a warning that wasn't given can lead to a negligence claim.
How to reduce the risk:
Know your state's rule, and whether it names nurse practitioners or "mental health professionals" generally.
When a patient makes a threat, document exactly what was said, your assessment, who you consulted, and what you did.
Don't disclose more than the law allows or requires.
The same caution applies to involuntary holds. Who can initiate an emergency psychiatric hold is set by state law, so confirm that your state authorizes NPs before you sign or recommend one.
6. Boundary violations
Boundary allegations, from dual relationships to sexual misconduct, can end a career even when they're unfounded, and they almost always go to the board. Psych practice is especially exposed because of the nature of the therapeutic relationship.
How to reduce the risk:
Keep all patient communication on professional, documented channels. No personal texting or social media.
Don't treat friends, family members, or business contacts.
Use a chaperone where appropriate, and document gifts, unusual requests, or contact outside sessions.
If a patient's behavior toward you changes, talk to a colleague and consider a referral.
7. Ketamine, esketamine (Spravato), and TMS
Newer treatments come with their own rules, and coverage questions. FDA requires Spravato to be given under the Spravato REMS in a certified healthcare setting, with patients monitored for at least two hours after each dose (FDA label). FDA has also warned that compounded ketamine products, including oral forms, are not FDA-approved for any psychiatric disorder (FDA).
How to reduce the risk:
Follow the REMS requirements exactly, and document monitoring and discharge.
Get specific informed consent for off-label ketamine use.
Tell your malpractice carrier about ketamine, esketamine, or TMS before you start, and get its answer in writing. Don't assume a standard policy covers it.
Documentation habits that protect PMHNPs
Almost every risk above comes back to the record. A short checklist:
Document your reasoning, not just your conclusions.
Record the patient's location for every telehealth visit.
Note informed consent for medications, especially controlled and off-label ones.
Never alter a record after the fact. If you need to correct something, add a dated late entry.
Keep messages and portal communication in the chart.
If a claim or board complaint arrives
Report it to your insurer right away, before you respond to anyone.
Don't change or add to the record.
Don't discuss the case with the patient, their family, or colleagues, or online.
Let defense counsel handle the response, including to the board.
Gather your schedule and records so your attorney has what they need.
Whether your policy pays for a lawyer at the board, gives you consent to settle, and covers lost wages matters most at this moment. AANP notes that most employers don't provide disciplinary (license) coverage, and that employer or insurer policies usually let them settle your case even if you want to fight it (AANP). A settlement paid on your behalf can be reported to the National Practitioner Data Bank.
How insurance fits in
Good habits lower your risk, and the right policy covers what's left. For PMHNPs, the features that matter most are occurrence coverage (no tail to buy when you change jobs), license-board defense, HIPAA defense, telehealth coverage, and full consent to settle. If you're employed, your employer's policy is written to protect the organization, so it's worth having your own.
Coverage details, published 2026 program rates, and a W-2 vs. 1099 comparison are all in our psychiatric nurse practitioner malpractice insurance guide. More reading: Do NPs need their own malpractice insurance? · NP telehealth coverage · NP malpractice insurance after a claim
About the author
Jeff Schmidt, CarePro Insurance. Jeff is a licensed insurance agent (Arizona license #9086805) with 21 years of experience in healthcare liability insurance. He helps nurse practitioners, PMHNPs, and NP-owned practices get malpractice coverage through CarePro. Contact: 480-385-7372 · Jeff@CareProInsurance.com
